Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.

Oracle's stock has plummeted since hitting a high of $345 in September 2025. Will a record quarter quell fears?

Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...

Oracle CEO Clayton Magouyrk said on an earnings call the company's model of having customers provide data chips for new data center builds is working.

Oracle surpassed estimates for the quarter, and lifted its guidance for fiscal 2027 revenue. During the quarter, Oracle announced plans to raise $45 billion to $50 billion in the fiscal year to expand ...

Oracle shares surged about 12% on Wednesday after the software giant's upbeat revenue forecast eased concerns over its hefty ...

Oracle's revenue and earnings growth have both been accelerating, driven by RPO backlogs. Click here to read more about ORCL ...

Oracle on Tuesday predicted that the AI data ​center boom will power its revenue above Wall Street estimates well into 2027, sending its shares up 8.3% in extended trading.

Oracle Corporation is rated a Buy due to robust execution, margin inflection, and high potential cloud growth opportunity.

Oracle (ORCL) closed at $141.31 in the latest trading session, marking a -4.57% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 1.04%. Meanwhile, the Dow lost 1 ...